---
aliases:
  - RDY
  - Dr. Reddy's
  - Dr Reddy's Laboratories
---
#actor #pharma #india #public #generics

Dr Reddy's Laboratories -- Indian pharmaceutical company and major generics/biosimilars producer. Targeting 87 markets for generic semaglutide as [[Novo Nordisk]] patents expire internationally in 2026.

## Quick stats

| Metric | Value |
|--------|-------|
| Ticker | RDY (NYSE), DRREDDY (NSE) |
| HQ | Hyderabad, [[India]] |
| Focus | Generics, biosimilars, APIs |
| GLP-1 relevance | Generic semaglutide for international markets |

## Related

- [[Novo Nordisk]] -- semaglutide originator
- [[GLP-1 receptor agonists]] -- generic entry context
- [[India]] -- home market

*Stub -- expand when relevant*
